← Back to S&P 500 Dashboard
AMGN
HOLDAmgen Inc.
Healthcare · Rank #38 · Analyzed Apr 20, 2026
$355.30
Current Price
$671.22
Intrinsic Value
+198.8%
Upside/Downside
10/10
Score
3.5/5
Quality
Analysis Summary
Valuation Consensus1/3 methods agree
Quality Score3.5/5.0
Framework RatingHOLD
Price vs Intrinsic ValueUndervalued by 198.8%
Fair Value Range
Low$12.85
Base (IV)$671.22
High$1061.51
Entry Points
Conservative$12.85
Moderate$342.03
Aggressive$671.22
Quality & Moat Breakdown
Return on Equity106.1% → 1.0/1.0
Debt LevelD/E 640 → 0/1.0
Revenue QualityGrowth -6.4%, margin Δ+45.4% +recovery → 0.5/1.0
Moat Strength4.0/5 → 1.0/1.0
Profit Margins21.0% → 1.0/1.0
Methodology
This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.
Learn how this framework works →This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.